PLoS ONE,
Journal Year:
2025,
Volume and Issue:
20(3), P. e0320287 - e0320287
Published: March 31, 2025
Image-based
cell
phenotyping
is
fundamental
in
both
biology
and
medicine.
As
cells
are
dynamic
systems,
based
on
static
data
complemented
by
extracted
from
time-dependent
characteristics.
We
developed
a
label-free
automatic
tracking
method
for
phase
contrast
images.
examined
the
possibility
of
using
motility-based
discrimination
to
identify
different
types
mesenchymal
migration
invasive
malignant
cancer
non-cancer
cells.
These
were
cultured
plastic
tissue
culture
vessels,
motility
parameters
trajectories
with
tracking.
Correlation
analysis
these
identified
characteristic
HT1080
fibrosarcoma
3T3-Swiss
fibroblast
lines.
The
parameter
“sum
turn
angles,”
combined
“frequency
turns”
at
shallow
angles
“migration
speed,”
proved
effective
highlighting
characteristics
It
revealed
differences
their
mechanisms
generating
propulsive
forces.
requirements
characterize
included
spatiotemporal
resolution
segmentation
tracking,
capable
detecting
polarity
changes
associated
morphological
alterations
body
displacement.
With
proposed
here,
curve
computed
quadratic
angles”
turns
below
30°”
gave
best
performance
94%
sensitivity.
Cell
process
related
not
only
but
also
healing
growth.
methodology
easy
use,
enabling
anyone
without
professional
skills
image
analysis,
large
training
datasets,
or
special
devices.
has
potential
application
broad
range
applications
basic
research.
Validating
expandability
this
migration,
including
scheme
force
generation,
an
important
consideration
future
study.
The Journal of Cell Biology,
Journal Year:
2023,
Volume and Issue:
223(1)
Published: Dec. 13, 2023
Cell
polarity,
which
consists
of
the
morphological,
structural,
and
functional
organization
cells
along
a
defined
axis,
is
feature
healthy
tissues.
In
contrast,
abnormal
polarity
hallmark
cancer
cells.
At
molecular
level,
key
evolutionarily
conserved
proteins
that
control
establishment
maintenance
in
various
contexts
are
frequently
altered
cancer,
but
relevance
these
alterations
oncogenic
processes
not
always
clear.
Here,
we
summarize
recent
findings,
shedding
new
light
on
involvement
players
development,
discuss
possibility
harnessing
cell
changes
to
better
predict,
diagnose,
cure
cancers.
Cancers,
Journal Year:
2024,
Volume and Issue:
16(14), P. 2580 - 2580
Published: July 18, 2024
Curcumin,
a
polyphenolic
compound
derived
from
Curcuma
longa,
exhibits
significant
therapeutic
potential
in
cancer
management.
This
review
explores
curcumin’s
mechanisms
of
action,
the
challenges
related
to
its
bioavailability,
and
enhancement
through
modern
technology
approaches.
Curcumin
demonstrates
strong
antioxidant
anti-inflammatory
properties,
contributing
ability
neutralize
free
radicals
inhibit
inflammatory
mediators.
Its
anticancer
effects
are
mediated
by
inducing
apoptosis,
inhibiting
cell
proliferation,
interfering
with
tumor
growth
pathways
various
colon,
pancreatic,
breast
cancers.
However,
clinical
application
is
limited
poor
bioavailability
due
rapid
metabolism
low
absorption.
Novel
delivery
systems,
such
as
curcumin-loaded
hydrogels
nanoparticles,
have
shown
promise
improving
curcumin
efficacy.
Additionally,
photodynamic
therapy
has
emerged
complementary
approach,
where
light
exposure
enhances
modulating
molecular
crucial
for
survival.
Studies
highlight
that
combining
concentrations
visible
irradiation
significantly
boosts
antitumor
efficacy
compared
alone.
The
interaction
cytochromes
or
drug
transporters
may
play
role
altering
pharmacokinetics
conventional
medications,
which
necessitates
careful
consideration
settings.
Future
research
should
focus
on
optimizing
understanding
fully
harness
treatment.
Cancers,
Journal Year:
2023,
Volume and Issue:
15(15), P. 3836 - 3836
Published: July 28, 2023
Cancer
is
an
impending
bottleneck
in
the
advanced
scientific
workflow
to
achieve
diagnostic,
prognostic,
and
therapeutic
success.
Most
cancers
are
refractory
conventional
diagnostic
chemotherapeutics
due
their
limited
targetability,
specificity,
solubility,
side
effects.
The
inherent
ability
of
each
cancer
evolve
through
various
genetic
epigenetic
transformations
metabolic
reprogramming
underlies
limitations.
Though
tumor
microenvironments
(TMEs)
quite
well
understood
some
cancers,
microenvironment
differs
from
other
internal
perturbations
skew
thereby
impeding
development
appropriate
diagnostics,
drugs,
vaccines,
therapies.
associated
bioenergetics
modulations
regulate
TME,
angiogenesis,
immune
evasion,
generation
resistant
niches
progression,
a
thorough
understanding
crucial
However,
this
remains
missing
element
theranostics,
necessitating
modalities
that
can
be
adapted
for
diagnostics
therapeutics.
In
challenging
scenario,
nanomaterials
modular
platforms
TME
achieving
successful
theranostics.
Several
nanoscale
particles
have
been
successfully
researched
animal
models,
few
reached
clinical
trials,
achieved
Nanoparticles
exhibit
intrinsic
capability
interact
with
diverse
biomolecules
modulate
functions.
Furthermore,
nanoparticles
functionalized
receptors,
modulators,
drugs
facilitate
specific
targeting
reduced
toxicity.
This
review
discusses
current
different
theranostic
nanosystems,
synthesis,
functionalization,
targetability
modulation
bioenergetics,
microenvironment.
We
highlight
potential
nanosystems
enhanced
chemotherapeutic
success
emphasizing
questions
remain
unanswered.
Biomolecules,
Journal Year:
2023,
Volume and Issue:
13(11), P. 1604 - 1604
Published: Nov. 1, 2023
The
ability
of
cancer
cells
to
detach
from
the
primary
site
and
metastasize
is
main
cause
cancer-
related
death
among
all
types.
Epithelial-to-mesenchymal
transition
(EMT)
first
event
metastatic
cascade,
resulting
in
loss
cell–cell
adhesion
acquisition
motile
stem-like
phenotypes.
A
critical
modulator
EMT
stromal
tumor
microenvironment
(TME),
which
can
promote
a
mesenchymal
phenotype
through
direct
interaction
with
or
changes
broader
microenvironment.
In
this
review,
we
will
explore
role
modulating
cell
EMT,
particular
emphasis
on
function
stromal/stem
(MSCs)
activation
EMT-inducing
pathways,
extra
cellular
matrix
(ECM)
remodeling,
immune
alteration,
metabolic
rewiring.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(15), P. 8352 - 8352
Published: July 30, 2024
Adipose
tissue
dysfunction,
which
is
associated
with
an
increased
risk
of
colorectal
cancer
(CRC),
a
significant
factor
in
the
pathophysiology
obesity.
Obesity-related
inflammation
and
extracellular
matrix
(ECM)
remodeling
promote
metastasis
(CRCM)
by
shaping
tumor
microenvironment
(TME).
When
CRC
occurs,
metabolic
symbiosis
cells
recruits
adjacent
adipocytes
into
TME
to
supply
energy.
Meanwhile,
abundant
immune
cells,
from
adipose
blood,
are
recruited
TME,
stimulated
pro-inflammatory
factors
triggers
chronic
local
TME.
Dysregulated
ECM
proteins
cell
surface
adhesion
molecules
enhance
further
increase
contractibility
between
stromal
promotes
epithelial-mesenchymal
transition
(EMT).
EMT
increases
migration
invasion
surrounding
tissues
or
vessels
accelerates
CRCM.
Colorectal
symbiotic
microbiota
also
plays
important
role
promotion
In
this
review,
we
provide
its
contributions
CRC,
special
emphasis
on
adipocytes,
macrophages,
neutrophils,
T
ECM,
gut
progression
their
microenvironment.
We
highlight
interactions
potential
therapeutic
approaches
target
these
interactions.
Clinical & Experimental Metastasis,
Journal Year:
2024,
Volume and Issue:
41(5), P. 567 - 587
Published: March 15, 2024
Abstract
As
a
major
energy
source
for
cells,
mitochondria
are
involved
in
cell
growth
and
proliferation,
as
well
migration,
fate
decisions,
many
other
aspects
of
cellular
function.
Once
thought
to
be
irreparably
defective,
mitochondrial
function
cancer
cells
has
found
renewed
interest,
from
suggested
potential
clinical
biomarkers
mitochondria-targeting
therapies.
Here,
we
will
focus
on
the
effect
movement
breast
progression.
Mitochondria
move
both
within
cell,
such
localize
areas
high
energetic
need,
between
where
stroma
have
been
shown
donate
their
via
multiple
methods
including
tunneling
nanotubes.
The
donation
seen
increase
aggressiveness
chemoresistance
which
increased
recent
efforts
uncover
mechanisms
transfer.
metabolism
energetics
gaining
attention
targets,
better
understanding
implications
required
developing
effective,
targeted
therapeutics
patients.
Biology,
Journal Year:
2024,
Volume and Issue:
13(7), P. 543 - 543
Published: July 18, 2024
Ferroptosis
is
a
novel
and
iron-dependent
form
of
programmed
cell
death,
which
has
been
implicated
in
the
pathogenesis
various
human
cancers.
EBV
well-recognized
oncogenic
virus
that
controls
multiple
signaling
pathways
within
host
cell,
including
ferroptosis
signaling.
Recent
studies
show
inducing
could
be
an
efficient
therapeutic
strategy
for
EBV-associated
tumors.
This
review
will
firstly
describe
mechanism
ferroptosis,
then
summarize
infection
tumors,
as
well
crosstalk
between
pathway,
finally
discuss
role
potential
application
ferroptosis-related
reagents
Autophagy,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 16, 2025
Macropinocytosis
is
a
nonselective
form
of
endocytosis
that
allows
cancer
cells
to
largely
take
up
the
extracellular
fluid
and
its
contents,
including
nutrients,
growth
factors,
etc.
We
first
elaborate
meticulously
on
process
macropinocytosis.
Only
by
thoroughly
understanding
this
entire
can
we
devise
targeted
strategies
against
it.
then
focus
central
role
MTOR
(mechanistic
target
rapamycin
kinase)
complex
1
(MTORC1)
in
regulating
macropinocytosis,
highlighting
significance
as
key
signaling
hub
where
various
pathways
converge
control
nutrient
uptake
metabolic
processes.
The
article
covers
comprehensive
analysis
literature
molecular
mechanisms
governing
initiation,
maturation,
recycling
macropinosomes,
with
an
emphasis
how
these
processes
are
hijacked
sustain
their
growth.
Key
discussions
include
potential
therapeutic
targeting
such
enhancing
drug
delivery
via
pathway,
inhibiting
macropinocytosis
starve
cells,
blocking
degradation
inducing
methuosis
–
cell
death
triggered
excessive
Targeting
represents
novel
innovative
approach
could
significantly
advance
treatment
cancers
rely
pathway
for
survival.
Through
continuous
research
innovation,
look
forward
developing
more
effective
safer
anti-cancer
therapies
will
bring
new
hope
patients.